DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

0.95USD
21 Nov 2014
Price Change (% chg)

$-0.01 (-1.04%)
Prev Close
$0.96
Open
$1.05
Day's High
$1.05
Day's Low
$0.91
Volume
164,176
Avg. Vol
72,859
52-wk High
$2.29
52-wk Low
$0.68

DRRX.OQ

Chart for DRRX.OQ

About

Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New... (more)

Overall

Beta: 1.23
Market Cap (Mil.): $109.13
Shares Outstanding (Mil.): 113.68
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 269.72 39.20
EPS (TTM): -0.19 -- --
ROI: -57.94 -1.77 17.16
ROE: -89.09 -3.18 18.09
Search Stocks

Pfizer ends deal with Pain Therapeutics to develop Durect's pain drug

- Pfizer Inc ended an agreement with Pain Therapeutics Inc to develop and market Durect Corp's pain drug, Remoxy, sending the stocks of the two smaller drugmakers plummeting.

27 Oct 2014

Pfizer ends deal with Pain Therapeutics to develop Durect's pain drug

Oct 27 - Pfizer Inc ended an agreement with Pain Therapeutics Inc to develop and market Durect Corp's pain drug, Remoxy, sending the stocks of the two smaller drugmakers plummeting.

27 Oct 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks